Show Me the Money
Breaking Down the Royalty Distribution for Licensed Inventions by Mitch Dozier, Director of Operations & Finance, OTC So, your novel idea is a success–congratulations! Now that the agreement is generating or will generate revenue, you’re…
Newly published data shows positive results in KRYSTEXXA trial
MIRROR Open-Label Trial Data Published in Journal of Rheumatology Show 79 Percent of Patients Achieved a Complete Response Using KRYSTEXXA® (pegloticase injection) with Methotrexate — Data adds to growing body of evidence on immunomodulation with KRYSTEXXA and emerging…
AWS Announces General Availability of Amazon Braket
Amazon Braket helps developers and researchers get started with quantum computing, providing development tools, simulators, and access to a diverse set of quantum hardware. Fidelity Investments, Volkswagen, Enel, University of Waterloo, Rahko, and Qu & Co…
Uplizna launch is a ‘testament’ to NC’s prowess in drug R&D
When singer songwriter Joni Mitchell wrote “…you don’t know what you’ve got ‘til it’s gone,” she didn’t know Thomas F. Tedder, Ph.D. Tedder, the Alter Geller Professor for Research in Immunology at Duke University Medical…
Working and collaborating with University Technology Transfer Offices
The third podcast of Venture Connect online with partners Wilson Sonsini Goodrich and Rosati: The three great universities that form the vertices of the Triangle of North Carolina are engines of innovation for its ecosystems. Every year these…
Duke Licensee Genetron Health Prices $256M US IPO
Beijing-based Genetron Health on Friday announced pricing of its previously announced initial public offering of 16,000,000 American Depositary Shares, each representing five ordinary company shares at $16.00 per ADS. The gross proceeds from the initial public offering…
COVID-19 Licensing Guidelines
The COVID-19 pandemic has rapidly moved the work of technology transfer offices from university and other non-profit research organizations to the battle’s front line. In order to support Membership worldwide and enable a swift end…
Bloom Science Granted Exclusive Option to License Gut Microbiome-based Therapies for ALS, Other Neurological Disorders
Bloom Science and Duke University have entered into an exclusive licensing agreement that provides the biopharmaceutical company access to the intellectual property and technology related to unique strain isolates and genetic variants of Akkermansia genus bacteria. This type of…
SeaSpine® Announces Exclusive Development and Licensing Agreement with restor3D®
September 24, 2019 CARLSBAD, Calif., Sept. 24, 2019 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it…